Effects of epigallocatechin-3-gallate on rat retinal ganglion cells after optic nerve axotomy. 2010

Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
Department of Ophthalmology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.

The purpose of this study was to investigate the effects of epigallocatechin-3-gallate (EGCG) in axotomized eyes and the pathways related to its action. Wistar rats received intracranial optic nerve (ON) axotomy 2 mm behind the globe in left eyes, whereas right eyes received sham operations. EGCG was administrated via intraperitoneal injection 30 min before and 4 days after axotomy. The density of retinal ganglion cell (RGC) was examined by a retrograde labeling technique. Western blot analysis was used to assess the expression of neuronal nitric oxide synthase (nNOS), Bax, Bcl-2, ERK and Akt. Optic nerve axotomy caused 54% RGC loss 7 days following surgery, and EGCG treatment reduced RGC loss by 12% (P = 0.017). The expression of the nNOS and pro-apoptotic Bax proteins were increased 5 days after axotomy, while EGCG treatment significantly blunted the up-regulation of the above two proteins (P = 0.04 and 0.02, respectively). Axotomy-induced p-ERK 1/2 and p-Akt proteins expression 5 days and 3 days following injury, respectively. Treatment with EGCG further enhanced p-ERK 1/2 and p-Akt expressions after axotomy. Inhibition of ERK and Akt pathways attenuated the protection of EGCG on RGC against axotomy damage. Thus, we demonstrated that administration of EGCG prior to axotomy promotes RGC survival. The neuroprotective capacity of EGCG appears to act through mediating nitric oxide, anti-apoptotic, and cell survival signaling pathways.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D009900 Optic Nerve The 2nd cranial nerve which conveys visual information from the RETINA to the brain. The nerve carries the axons of the RETINAL GANGLION CELLS which sort at the OPTIC CHIASM and continue via the OPTIC TRACTS to the brain. The largest projection is to the lateral geniculate nuclei; other targets include the SUPERIOR COLLICULI and the SUPRACHIASMATIC NUCLEI. Though known as the second cranial nerve, it is considered part of the CENTRAL NERVOUS SYSTEM. Cranial Nerve II,Second Cranial Nerve,Nervus Opticus,Cranial Nerve, Second,Cranial Nerves, Second,Nerve, Optic,Nerve, Second Cranial,Nerves, Optic,Nerves, Second Cranial,Optic Nerves,Second Cranial Nerves
D002392 Catechin An antioxidant flavonoid, occurring especially in woody plants as both (+)-catechin and (-)-epicatechin (cis) forms. Catechinic Acid,Catechuic Acid,(+)-Catechin,(+)-Cyanidanol,(+)-Cyanidanol-3,(-)-Epicatechin,(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol,2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-,3,3',4',5,7-Flavanpentol,Catergen,Cianidanol,Cyanidanol-3,Epicatechin,KB-53,Z 7300,Zyma,Cyanidanol 3,KB 53,KB53
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012165 Retinal Ganglion Cells Neurons of the innermost layer of the retina, the internal plexiform layer. They are of variable sizes and shapes, and their axons project via the OPTIC NERVE to the brain. A small subset of these cells act as photoreceptors with projections to the SUPRACHIASMATIC NUCLEUS, the center for regulating CIRCADIAN RHYTHM. Cell, Retinal Ganglion,Cells, Retinal Ganglion,Ganglion Cell, Retinal,Ganglion Cells, Retinal,Retinal Ganglion Cell
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
January 2012, Cell death and differentiation,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
April 2000, Investigative ophthalmology & visual science,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
October 2001, Neuroreport,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
February 2009, European journal of pharmacology,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
September 2015, Investigative ophthalmology & visual science,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
July 2010, Neuroscience letters,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
March 1990, Proceedings of the National Academy of Sciences of the United States of America,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
August 2009, Investigative ophthalmology & visual science,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
February 1995, Current eye research,
Pai-Huei Peng, and Lan-Fen Chiou, and Hsiao-Ming Chao, and Shan Lin, and Chau-Fong Chen, and Jorn-Hon Liu, and Mei-Lan Ko
December 2002, The Journal of biological chemistry,
Copied contents to your clipboard!